501 related articles for article (PubMed ID: 6358257)
1. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core.
Pollack M; Huang AI; Prescott RK; Young LS; Hunter KW; Cruess DF; Tsai CM
J Clin Invest; 1983 Dec; 72(6):1874-81. PubMed ID: 6358257
[TBL] [Abstract][Full Text] [Related]
2. Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man.
Pollack M; Young LS
J Clin Invest; 1979 Feb; 63(2):276-86. PubMed ID: 429553
[TBL] [Abstract][Full Text] [Related]
3. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
Tyler JW; Spears H; Nelson R
J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulins in the hyperimmunoglobulin E and recurrent infection (Job's) syndrome. Deficiency of anti-Staphylococcus aureus immunoglobulin A.
Dreskin SC; Goldsmith PK; Gallin JI
J Clin Invest; 1985 Jan; 75(1):26-34. PubMed ID: 3871199
[TBL] [Abstract][Full Text] [Related]
5. Hyperimmunization of steers with J5 Escherichia coli bacterin: effects on isotype-specific serum antibody responses and cross reactivity with heterogeneous gram-negative bacteria.
Chaiyotwittayakun A; Burton JL; Weber PS; Kizilkaya K; Cardoso FF; Erskine RJ
J Dairy Sci; 2004 Oct; 87(10):3375-85. PubMed ID: 15377616
[TBL] [Abstract][Full Text] [Related]
6. Comparison of serological specificity of anti-endotoxin sera directed against whole bacterial cells and core oligosaccharide of Escherichia coli J5-tetanus toxoid conjugate.
Lukasiewicz J; Jachymek W; Niedziela T; Malik-Gebicka M; Dzieciatkowska M; Lugowski C
Acta Biochim Pol; 2002; 49(3):721-34. PubMed ID: 12422242
[TBL] [Abstract][Full Text] [Related]
7. Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms.
Opal SM; Palardy JE; Chen WH; Parejo NA; Bhattacharjee AK; Cross AS
J Infect Dis; 2005 Dec; 192(12):2074-80. PubMed ID: 16288370
[TBL] [Abstract][Full Text] [Related]
8. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of antibodies against gram-negative core antigens in rabbits, using an Escherichia coli J5 antigen-capture enzyme-linked immunosorbent assay.
Ruble RP; Cullor JS; Brooks DL
Am J Vet Res; 1999 Apr; 60(4):501-6. PubMed ID: 10211696
[TBL] [Abstract][Full Text] [Related]
10. Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis.
Dunn DL; Mach PA; Condie RM; Cerra FB
Surgery; 1984 Aug; 96(2):440-6. PubMed ID: 6379963
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis.
Dunn DL; Bogard WC; Cerra FB
Surgery; 1985 Aug; 98(2):283-90. PubMed ID: 3895540
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS
Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399
[TBL] [Abstract][Full Text] [Related]
13. Endotoxin-neutralizing capacity of serum from cardiac surgical patients.
Bennett-Guerrero E; Barclay GR; Weng PL; Bodian CA; Feierman DE; Vela-Cantos F; Mythen MG
J Cardiothorac Vasc Anesth; 2001 Aug; 15(4):451-4. PubMed ID: 11505348
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of gram-negative bacterial sepsis: enhanced survival in a guinea pig model by use of rabbit antiserum to Escherichia coli J5.
Dunn DL; Ferguson RM
Surgery; 1982 Aug; 92(2):212-9. PubMed ID: 7048594
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
17. Enzyme-linked immunosorbent assay for detection of antibody to Pseudomonas aeruginosa and measurement of antibody titer in horse serum.
Ueda Y; Sanai Y; Homma JY
Am J Vet Res; 1982 Jan; 43(1):55-60. PubMed ID: 6807144
[TBL] [Abstract][Full Text] [Related]
18. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
[TBL] [Abstract][Full Text] [Related]
19. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).
Coughlin RT; Bogard WC
J Immunol; 1987 Jul; 139(2):557-61. PubMed ID: 3298431
[TBL] [Abstract][Full Text] [Related]
20. Alteration of the antibody response to Escherichia coli O antigen in mice by prior exposure to various somatic antigens.
Ahlstedt S; Holmgren J
Immunology; 1975 Sep; 29(3):487-96. PubMed ID: 51829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
